HBI Deals+Insights / News
Giant health care conglomerate Fresenius SE has publicly floated the possibility of bringing minority equity shareholders in at the level of divisions such as Vamed or Helios in its 2021 results announcement. It has even suggested it could sell its controlling stake in dialysis arm Fresenius Medical Care. But at least one investment bank is publicly stating this doesn't go far enough.